It is a metals and minerals private limited company based in Mumbai, Maharashtra, India, established in 1997.
1997 | Mumbai, Maharashtra, India | Struck OffHem Crysotiles Private Limited, a struck off private limited company, was established on 07 March 1997 in Mumbai, Maharashtra, India. Engaging in construction materials retail & distribution within the trade sector, it holds CIN: U26990MH1997PTC106418. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.21 M.
It upholds a active non-compliant status. Its leadership includes Ganesh Sharad Kelkar (Additional Director), Bhushan Raghunath Mali (Additional Director). Past directors included Sangeeta Vinod Motwani, Sunita Raja Hemwani, Raja Hemwani. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at Flat No 1, 2Nd Floor, H M Tower Bandra (W) Junction Of 24Th & 29 Th Road, Mumbai, Maharashtra, 400050.
U26990MH1997PTC106418
106418
07 March 1997
₹2.50 M
₹0.21 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Hem Crysotiles Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesh Sharad Kelkar | Additional Director | 26 Nov 2018 | Current |
| Bhushan Raghunath Mali | Additional Director | 22 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Nov 2018 | Past |
| Pramod Abcsdd | Additional Director | 01 Dec 2016 | Past |
| Pramod Abcsdd | Director | 01 Dec 2016 | Past |
| Pramod Abcsdd | Director | 28 Feb 2017 | Past |
| Pramod Abcsdd | Director | 18 Nov 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hem Crysotiles Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 71842.87% increase. The company also saw a substantial improvement in profitability, with a 11420.49% increase in profit. The company's net worth Soared by an impressive increase of 13.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Hem Crysotiles had a promoter holding of 98.83% and a public holding of 1.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hem Crysotiles, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hem Crysotiles, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hem Crysotiles's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ganesh Sharad Kelkar was appointed as a Additional Director was appointed as a Additional Director on 26 Nov 2018 & has been associated with this company since 7 years 6 days . was completed.
The activity Bhushan Raghunath Mali was appointed as a Additional Director was appointed as a Additional Director on 22 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
Hem Crysotiles Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was recorded as a recent event.
Hem Crysotiles Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai. was recorded as a recent event.
The activity Hem Crysotiles Private Limited was registered on 07 Mar 1997 with Roc Mumbai & aged 28 years 8 months as per MCA records. was completed.
The CIN of Hem Crysotiles Private Limited is U26990MH1997PTC106418.
Hem Crysotiles Private Limited is headquartered at Flat No 1, 2Nd Floor, H M Tower Bandra (W) Junction Of 24Th & 29 Th Road, Mumbai, Maharashtra, 400050.
Hem Crysotiles Private Limited was incorporated on 07 March 1997.
The current directors of Hem Crysotiles Private Limited are
The primary industry of Hem Crysotiles Private Limited is Trade.
Hem Crysotiles Private Limited is unlisted.
The authorized capital of Hem Crysotiles Private Limited is ₹2.50 M, and the paid-up capital is ₹0.21 M.
The compliance status of Hem Crysotiles Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX